Literature DB >> 16415105

Mycobacterium tuberculosis in the adjuvant modulates the balance of Th immune response to self-antigen of the CNS without influencing a "core" repertoire of specific T cells.

Chiara Nicolò1, Gabriele Di Sante, Massimiliano Orsini, Simona Rolla, Sandra Columba-Cabezas, Vincenzo Romano Spica, Gualtiero Ricciardi, Bosco Man Chu Chan, Francesco Ria.   

Abstract

In the present study, we use modified CDR3 beta-chain spectratyping (immunoscope) to dissect the effect of Mycobacterium tuberculosis (MT)-derived proteins on individual PLP139-151-specific cells in the SJL mouse strain. In this model, the immunoscope technique allows the characterization of a public TCR that involves rearrangement of Vbeta10 and Jbeta1.1 and a semi-private TCR characterized by rearrangement of Vbeta4 and Jbeta1.6. Both rearrangements are specific for PLP139-151 and sequences of the CDR3 region of the two beta-chains show a conserved motif for the public rearrangement and related but more variable sequences for the semi-private rearrangement. MT-derived proteins promote increase of IFN-gamma-secreting cells. However, we observe that the presence and amount of MT used during immunization have no effect on the frequency of usage, polarization and in vivo expansion of cells carrying the studied rearrangements. Rather, the strong Th1-promoting effect of adjuvant is possibly due to recruitment toward Th1 of a wider spectrum of TCR repertoires. Therefore, instead of having a comprehensive effect on the entire repertoire, MT modulates the immune response by affecting a subset of antigen-specific T cells whose polarization can be adapted to the environment. This step establishes the final balance between Th1 and Th2 and may be essential for the enhancement or protection of disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415105     DOI: 10.1093/intimm/dxh376

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice.

Authors:  Michela Sali; Gabriele Di Sante; Alessandro Cascioferro; Antonella Zumbo; Chiara Nicolò; Valentina Donà; Stefano Rocca; Annabella Procoli; Matteo Morandi; Francesco Ria; Giorgio Palù; Giovanni Fadda; Riccardo Manganelli; Giovanni Delogu
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  M tuberculosis in the adjuvant modulates time of appearance of CNS-specific effector T cells in the spleen through a polymorphic site of TLR2.

Authors:  Chiara Nicolò; Gabriele Di Sante; Annabella Procoli; Giuseppe Migliara; Alessia Piermattei; Mariagrazia Valentini; Giovanni Delogu; Achille Cittadini; Gabriela Constantin; Francesco Ria
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

3.  Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis.

Authors:  Alessia Piermattei; Giuseppe Migliara; Gabriele Di Sante; Maria Foti; Soren Bohos Hayrabedyan; Angela Papagna; Maria Concetta Geloso; Maddalena Corbi; Mariagrazia Valentini; Alessandro Sgambato; Giovanni Delogu; Gabriela Constantin; Francesco Ria
Journal:  Front Immunol       Date:  2016-05-24       Impact factor: 7.561

4.  Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis.

Authors:  Gabriele Di Sante; Barbara Tolusso; Anna Laura Fedele; Elisa Gremese; Stefano Alivernini; Chiara Nicolò; Francesco Ria; Gianfranco Ferraccioli
Journal:  EBioMedicine       Date:  2015-11-17       Impact factor: 8.143

5.  PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis M.smegmatis model.

Authors:  Giuseppe Migliara; Martin Mueller; Alessia Piermattei; Chaya Brodie; Michael J Paidas; Eytan R Barnea; Francesco Ria
Journal:  Oncotarget       Date:  2017-03-28

6.  A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis.

Authors:  Maria Tredicine; Chiara Camponeschi; Davide Pirolli; Matteo Lucchini; Mariagrazia Valentini; Maria Concetta Geloso; Massimiliano Mirabella; Marco Fidaleo; Benedetta Righino; Camilla Moliterni; Ezio Giorda; Mario Rende; Maria Cristina De Rosa; Maria Foti; Gabriela Constantin; Francesco Ria; Gabriele Di Sante
Journal:  iScience       Date:  2022-01-11

7.  Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis.

Authors:  Francesco Ria; Romina Penitente; Maria De Santis; Chiara Nicolò; Gabriele Di Sante; Massimiliano Orsini; Dario Arzani; Andrea Fattorossi; Alessandra Battaglia; Gian Franco Ferraccioli
Journal:  Arthritis Res Ther       Date:  2008-11-17       Impact factor: 5.156

8.  Immune imbalance in nasal polyps of Caucasian chronic rhinosinusitis patients is associated with a downregulation of E-selectin.

Authors:  Michael Könnecke; Robert Böscke; Anja Waldmann; Karl-Ludwig Bruchhage; Robert Linke; Ralph Pries; Barbara Wollenberg
Journal:  J Immunol Res       Date:  2014-06-03       Impact factor: 4.818

Review 9.  T Cell Receptor Profiling in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Amanda Posgai; Howard R Seay; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2017-10-11       Impact factor: 4.810

10.  The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing-Remitting Multiple Sclerosis Mouse Model.

Authors:  Gabriele Di Sante; Susanna Amadio; Beatrice Sampaolese; Maria Elisabetta Clementi; Mariagrazia Valentini; Cinzia Volonté; Patrizia Casalbore; Francesco Ria; Fabrizio Michetti
Journal:  Cells       Date:  2020-03-18       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.